Highmark Health has announced a $25 million grant to support specialized cancer care and research at Penn State Cancer Institute.
The companies said the grant will be used toward the development of new cancer treatment drugs, clinical trials, and to recruit leading cancer researchers.
Penn State Cancer Institute is based at the Penn State Health Milton S. Hershey Medical Center campus. Research is conducted in Hershey and at Penn State’s main campus.
“Penn State is among the leading research universities in the world, and we are committed to using that work to improve the lives of people across the region who are suffering from chronic and life-threatening conditions,” Penn State President Eric Barron said. “We are very grateful that Highmark is partnering with us in the fight to conquer cancer and to invest in the future of health care.”
At a news conference announcing the grant on Thursday, Health Secretary Dr. Rachel Levine said cancer is the second-leading cause of death among Pennsylvanians.
Last year, more than 78,000 people in the state were diagnosed with cancer and more than 28,000 died.